Altace

   
Google
 
Web NewDrugInformation.com

Altace


Drug - Altace
The trade name of the product as shown on the labeling.

Dosage - CAPSULE; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Ramipril
Multiple ingredients are in alphabetical order.

Strength - 1.25MG
The potency of the active ingredient(s), Ramipril. May repeat for multiple part products.

Applicant - KING PHARMS
The firm name holding legal responsibility for Altace. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019901
The FDA assigned number to Altace. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Altace. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jan 28, 1991
The date Altace was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Altace. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Altace is in. Format is RX, OTC, DISCN.

Applicant Full Name - King Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Altace.

Altace